Telomeres: Astragalus and the Future of K-Anti-Aging

reduction in patients with myocardial infarction, as well as the potential anti-aging properties of the traditional herbal medicine Astragalus membranaceus. The first source presents clinical trial results demonstrating that TA-65 increases key lymphocyte subsets and reduces inflammatory markers. The second source discusses how cycloastragenol, a compound derived from Astragalus, can activate the telomerase enzyme and potentially delay cellular aging. Both sources highlight the positive impact of TA-65 on immune function, while emphasizing the scientific potential of Astragalus in anti-aging therapy.